SCOTUS Overturns 340B Drug Pricing Reimbursement Reductions
Supreme Court issued American Hospital Association et. al. v. Becerra opinion overturning massive reimbursement reductions in 340B drug pricing program. 340B Program requires drug manufacturers to provide outpatient drugs to participating providers at discounted rates.